Oncology Medical News about bladder cancer

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Investigation of a new 1,3-diarylpropenone as a potential antimitotic agent targeting bladder carcinoma
Anti-Cancer Drugs, 07/02/09

Martel-Frachet V et al. - After treating the cells with IPP51 for 24 h, the title compound induced a predominant and reversible G2+M accumulation at the prometaphase stage of mitosis. However, when used for a longer period, it leads to cell apoptosis. These results suggest that the compound has potential anticancer activities, which could be useful in bladder cancer treatment.

<< Previous
Nitroimidazole-based bioreductive compounds bearing a quinazoline...

Next >>
Efficient activation of p53 pathway in A549 cells exposed to L2,...